Open-source automated insulin delivery: international consensus statement and practical guidance for health-care professionals
K Braune, RA Lal, L Petruželková… - The Lancet Diabetes & …, 2022 - thelancet.com
Open-source automated insulin delivery systems, commonly referred to as do-it-yourself
automated insulin delivery systems, are examples of user-driven innovations that were co …
automated insulin delivery systems, are examples of user-driven innovations that were co …
Real‐world evidence on clinical outcomes of people with type 1 diabetes using open‐source and commercial automated insulin dosing systems: A systematic review
C Knoll, S Peacock, M Wäldchen, D Cooper… - Diabetic …, 2022 - Wiley Online Library
Aims Several commercial and open‐source automated insulin dosing (AID) systems have
recently been developed and are now used by an increasing number of people with …
recently been developed and are now used by an increasing number of people with …
[HTML][HTML] Open-source automated insulin delivery in type 1 diabetes
MJ Burnside, DM Lewis, HR Crocket… - … England Journal of …, 2022 - Mass Medical Soc
Background Open-source automated insulin delivery (AID) systems are used by many
patients with type 1 diabetes. Data are needed on the efficacy and safety of an open-source …
patients with type 1 diabetes. Data are needed on the efficacy and safety of an open-source …
Real-world evidence of automated insulin delivery system use
EG Considine, JL Sherr - Diabetes Technology & Therapeutics, 2024 - liebertpub.com
Objective: Pivotal trials of automated insulin delivery (AID) closed-loop systems have
demonstrated a consistent picture of glycemic benefit, supporting approval of multiple …
demonstrated a consistent picture of glycemic benefit, supporting approval of multiple …
Glycemic control during Ramadan fasting in adolescents and young adults with type 1 diabetes on MiniMed™ 780g advanced hybrid closed‑loop system: a …
NS Elbarbary, EAR Ismail - Diabetes Research and Clinical Practice, 2022 - Elsevier
Abstract Background MiniMed TM 780G is the most advanced insulin pump system
approved for the treatment of type 1 diabetes mellitus (T1DM). Hypoglycemic events are a …
approved for the treatment of type 1 diabetes mellitus (T1DM). Hypoglycemic events are a …
[HTML][HTML] Large-scale data analysis for glucose variability outcomes with open-source automated insulin delivery systems
Open-source automated insulin delivery (AID) technologies use the latest continuous
glucose monitors (CGM), insulin pumps, and algorithms to automate insulin delivery for …
glucose monitors (CGM), insulin pumps, and algorithms to automate insulin delivery for …
Barriers to uptake of Open-Source automated insulin delivery Systems: Analysis of socioeconomic factors and perceived challenges of adults with type 1 diabetes from …
S O'Donnell, D Cooper, Y Chen, H Ballhausen… - Diabetes Research and …, 2023 - Elsevier
Aims Social and technical trends are empowering people with diabetes to co-create or self-
develop medical devices and treatments to address their unmet healthcare needs, for …
develop medical devices and treatments to address their unmet healthcare needs, for …
Celebrating the data from 100,000 real-world users of the MiniMed™ 780G system in Europe, Middle East, and Africa collected over 3 years: from data to clinical …
P Choudhary, A Arrieta, T van den Heuvel… - Diabetes Technology …, 2024 - liebertpub.com
Introduction: The present report celebrates the benchmarking of 100,000 MiniMed™ 780G
system users in Europe, Middle East, and Africa (EMEA) and summarizes the major insights …
system users in Europe, Middle East, and Africa (EMEA) and summarizes the major insights …
Safety and effectiveness of do‐it‐yourself artificial pancreas system compared with continuous subcutaneous insulin infusions in combination with free style libre in …
R Patel, TSJ Crabtree, N Taylor, L Langeland… - Diabetic …, 2022 - Wiley Online Library
Aims The use of do‐it‐yourself artificial pancreas systems (DIYAPS) among people with type
1 diabetes is increasing. At present, it is unclear how DIYAPS compares with other …
1 diabetes is increasing. At present, it is unclear how DIYAPS compares with other …
[HTML][HTML] Meal and physical activity detection from free-living data for discovering disturbance patterns of glucose levels in people with diabetes
Objective: The interpretation of time series data collected in free-living has gained
importance in chronic disease management. Some data are collected objectively from …
importance in chronic disease management. Some data are collected objectively from …